Office of National Drug Control Policy

Office of National Drug Control Policy

Office of National Drug Control Policy

Overview
Headquarters

750 17th St NW, Washington, DC, 20006, US

Type of Company

Private

Industries

Government

Company Description

The White House Office of National Drug Control Policy (ONDCP), a former cabinet level[1] component of the Executive Office of the President of the United States, was established in 1989 by the Anti-Drug Abuse Act of 1988. Its stated goal is to establish policies, priorities, and objectives to eradicate illicit drug use, manufacturing, and trafficking, drug-related crime and violence, and drug-related health consequences in the U.S.

Contact Data
Trying to get in touch with decision makers at Office of National Drug Control Policy? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Director

Assistant Deputy Director

Executive Secretariat

Senior Adviser for Rural Affairs

Special Advisor for Strategic Planning to the Director

Information Technology Manager

Paths to Office of National Drug Control Policy
Potential Connections via
Relationship Science
You
Office of National Drug Control Policy
Advisors & Consultants
Advisor

Head of Laboratory, Laboratory of the Biology of Addictive Diseases at The Rockefeller University

Consultant

Program Director, Addiction Recovery Management Service at The Massachusetts General Hospital

Advisor

Co-Chief Creative Officer at Havas North America, Inc.

Non-Profit Donations & Grants
$1,000 - $2,499
2000
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Office of National Drug Control Policy. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Office of National Drug Control Policy's profile does not indicate a business or promotional relationship of any kind between RelSci and Office of National Drug Control Policy.